Takeda Pharmaceutical Co., Japan's biggest drugmaker, sought U.S. approval to sell alogliptin as a once-daily treatment for type-2 diabetes, it said in a statement today. If approved, it will be the Osaka- based company's first new medicine released in the U.S. in more than two years. More...
As seen on MedGadget. com, the European Space Agency is reporting that technology originally developed for its space program has now been used to create the insulin pump of the future: one that you can wear on your wrist!.German student Nicole Schmiedel has come up with a design for a fashionable looking "wristwatch" that contains an innovative ultra-light insulin pump to help people with type 1 diabetes. For more, click here...
Enter keywords:
